Fentanyl reduces infarction but not stunning via δ-opioid receptors and protein kinase C in rats

British Journal of Anaesthesia

Volumn 84, Issue 5, 2000, Pages 608-614

  Kato, R ^a   Foex P ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

Analgesics, opioids, fentanyl; Enzymes, protein kinase C; Heart, myocardial ischaemia; Receptors, opioid

Indexed keywords

CHELERYTHRINE; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR ANTAGONIST; FENTANYL; NALTRINDOLE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STUNNED HEART MUSCLE;

EID: 0342804317     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/84.5.608     Document Type: Article

References (40)

1. Ross S, Foëx P. Protective effects of anaesthetics in reversible and irreversible ischaemia-reperfusion injury. Br J Anaesth 1999; 82: 633-2
2. Schultz JJ, Hsu AK, Gross GJ. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res 1996; 78: 1100-4
3. Schultz JJ, Hsu AK, Gross GJ. Ischemic preconditioning and morphine-induced cardioprotection involve the delta (δ)-opioid receptor in the intact rat heart. J Mol Cell Cardiol 1997; 29: 2187-95
4. Miki T, Cohen MV, Downey JM. Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits. Mol Cell Biochem 1998; 186: 3-12
5. Lawson CS, Downey JM. Preconditioning: state of the art myocardial protection. Cardiovasc Res 1993; 27: 542-50
6. Yellon DM, Baxter GF, Garcia Dorado D, Heusch G, Sumeray MS. Ischaemic preconditioning: present position and future directions. Cardiovasc Res 1998; 37: 21-33
7. Meldrum DR, Cleveland JC Jr, Rowland RT, Banerjee A, Harken AH, Meng X. Early and delayed preconditioning: differential mechanisms and additive protection. Am J Physiol 1997; 273: H725-33
8. ATP channels linked mechanism in rats. Br J Anaesth 2000; 84: 204-14
9. Bugge E, Ytrehus K. Bradykinin protects against infarction but does not mediate ischemic preconditioning in the isolated rat heart. J Mol Cell Cardiol 1996; 28: 2333-41
10. 1 receptor activation is abolished by protein kinase C inhibitors in the rabbit. Cardiovasc Res 1995; 29: 682-8
11. + channel. J Mol Cell Cardiol 1997; 29: 175-82
12. ATP channels in the isolated rat heart. Cardiovasc Res 1996; 32: 920-9
13. 1-Adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ Res 1994; 75: 576-85
14. Maguire P, Tsai N, Kamal J, Cometta Morini C, Upton C, Loew G. Pharmacological profiles of fentanyl analogs at μ, δ and κ opiate receptors. Eur J Pharmacol 1992; 213: 219-25
15. Zimlichman R, Gefel D, Eliahou H, et al. Expression of opioid receptors during heart ontogeny in normotensive and hypertensive rats. Circulation 1996; 93: 1020-5
16. Wong TM, Lee AY, Tai KK. Effects of drugs interacting with opioid receptors during normal perfusion or ischemia and reperfusion in the isolated rat heart - an attempt to identify cardiac opioid receptor subtype(s) involved in arrhythmogenesis.J Mol Cell Cardiol 1990; 22: 1167-75
17. Wu JP, Chen YT, Lee AY. Opioids in myocardial ischaemia: potentiating effects of dynorphin on ischaemic arrhythmia, bradycardia and cardiogenic shock following coronary artery occlusion in the rat. Eur Heart J 1993; 14: 1273-7
18. 1-but not μ-or κ-opioid receptors. Circulation 1998; 97: 1282-9
19. 1-opioid receptor agonist, reduces infarct size via activation of Gi/o proteins and KATP channels. Am J Physiol 1998; 274: H909-14
20. Tsuchida A, Miura T, Tanno M, Nozawa Y, Kita H, Shimamoto K. Time window for the contribution of the δ-opioid receptor to cardioprotection by ischemic preconditioning in the rat heart. Cardiovasc Drugs Ther 1998; 12: 365-73
21. Liang BT, Gross GJ. Direct preconditioning of cardiac myocytes via opioid receptors and KATP channels. Circ Res 1999; 84: 1396-400
22. Moolman JA, Genade S, Winterbach R, Harper IS, Williams K, Lochner A. Preconditioning with a single short episode of global ischemia in the isolated working rat heart: effect on structure, mechanical function, and energy metabolism for various durations of sustained global ischemia. Cardiovasc Drugs Ther 1995; 9: 103-15
23. Simkhovich BZ, Przyklenk K, Kloner RA. Role of protein kinase C as a cellular mediator of ischemic preconditioning: a critical review. Cardiovasc Res 1998; 40: 9-22
24. 2+ release from an intracellular pool in myocytes and neurons. Circ Res 1992; 70: 66-81
25. Sugden PH, Bogoyevitch MA. Intracellular signalling through protein kinases in the heart. Cardiovasc Res 1995; 30: 478-92
26. Lou LG, Pei G. Modulation of protein kinase C and cAMP-dependent protein kinase by δ-opioid. Biochem Biophys Res Commun 1997; 236: 626-9
27. Kramer HK, Simon EJ. Role of protein kinase C (PKC) in agonist-induced μ-opioid receptor down-regulation: II. Activation and involvement of the α, ε, and ζ isoforms of PKC. J Neurochem 1999; 72: 594-604
28. Brooks G, Hearse DJ. Role of protein kinase C in ischemic preconditioning: player or spectator? Circ Res 1996; 79: 627-30
29. Lasley RD, Noble MA, Mentzer RM Jr. Effects of protein kinase C inhibitors in in situ and isolated ischemic rabbit myocardium. J Mol Cell Cardiol 1997; 29: 3345-56
30. Lundmark JL, Ramasamy R, Vulleit PR, Schaefer S. Chelerythrine increases Na-K-ATPase activity and limits ischemic injury in isolated rat hearts. Am J Physiol 1999; 277: H999-1006
31. Bugge E, Ytrehus K. Ischaemic preconditioning is protein kinase C dependent but not through stimulation of alpha adrenergic or adenosine receptors in the isolated rat heart. Cardiovasc Res 1995; 29: 401-6
32. + channels and myocardial preconditioning. Circ Res 1999; 84: 973-9
33. 3 opiate receptor in endothelial cells. Coupling to nitric oxide production and vasodilation. J Biol Chem 1995; 270: 30290-3
34. Maxwell MP, Hearse DJ, Yellon DM. Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res 1987; 21: 737-46
35. Ping P, Takano H, Zhang J, Tang XL, Qiu Y, Li RC, et al. Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits: a signaling mechanism for both nitric oxide-induced and ischemia-induced preconditioning. Circ Res 1999; 84: 587-604
36. + channel openers in guinea-pig ventricular cells. Br J Pharmacol 1997; 120: 1568-74
37. Piriou V, Ross S, Pigott D, Evans R, Foëx P. Beneficial effect of concomitant administration of isoflurane and nicorandil. Br J Anaesth 1997; 79: 68-77
38. Hearse DJ. Myocardial protection during ischemia and reperfusion. Mol Cell Biochem 1998; 186: 177-84
39. Meldrum DR, Cleveland JC Jr, Meng X, Sheridan BC, Cain BS, Harken AH, et al. Protein kinase C isoform diversity in preconditioning. J Surg Res 1997; 69: 183-7
40. Ito WD, Schaarschmidt S, Klask R, Hansen S, Scafer HJ, Mathey D et al. Infarct size measurement by triphenyltetrazolium chloride staining versus in vivo injection of propidium iodide. J Mol Cell Cardial 1997; 29: 2169-7S